Stem cell therapies in age-related neurodegenerative diseases and stroke

Ageing Research Reviews

Volumn 34, Issue , 2017, Pages 39-50

  Wang, Yuan ^a   Ji, Xunming ^a   Leak, Rehana K ^b   Chen, Fenghua ^c   Cao, Guodong ^c,d  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b DUQUESNE UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Aging; Neurodegenerative diseases; Plasticity; Self renew; Stem cell; Stroke

Indexed keywords

ADIPOSE DERIVED STEM CELL; AGING; ALZHEIMER DISEASE; BASIC RESEARCH; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL LOSS; CELL REGENERATION; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DEGENERATIVE DISEASE; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; GRAY MATTER; HEMATOPOIETIC STEM CELL; HUMAN; INDUCED PLURIPOTENT STEM CELL; MOTOR DYSFUNCTION; NERVE CELL; NERVE CELL PLASTICITY; NEURAL STEM CELL; NONHUMAN; NUCLEAR REPROGRAMMING; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN MISFOLDING; REVIEW; STEM CELL SELF-RENEWAL; STEM CELL TRANSPLANTATION; STROKE PATIENT; SYNAPSE; UMBILICAL CORD BLOOD CELL; WHITE MATTER; ANIMAL; BRAIN; METABOLISM; NEURODEGENERATIVE DISEASES; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; STROKE;

AGING; ANIMALS; BRAIN; HUMANS; NEURODEGENERATIVE DISEASES; NEURONAL PLASTICITY; NEURONS; OXIDATIVE STRESS; STEM CELL TRANSPLANTATION; STROKE; SYNAPSES;

EID: 85007200900     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2016.11.002     Document Type: Review

References (197)

1. Alzheimer's Associationnon, Alzheimer's disease facts and figures. Alzheimers Dement 8 (2012), 131–168.
2. Alzheimer's Associationnon, Alzheimer's disease facts and figures. Alzheimers Dement 11 (2015), 332–384.
3. Araque, A., Carmignoto, G., Haydon, P.G., Oliet, S.H., Robitaille, R., Volterra, A., Gliotransmitters travel in time and space. Neuron 81 (2014), 728–739.
4. Arslan-Ergul, A., Ozdemir, A.T., Adams, M.M., Aging, neurogenesis, and caloric restriction in different model organisms. Aging Dis. 4 (2013), 221–232.
5. Arvidsson, A., Collin, T., Kirik, D., Kokaia, Z., Lindvall, O., Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat. Med. 8 (2002), 963–970.
6. Asplund, K., Karvanen, J., Giampaoli, S., Jousilahti, P., Niemela, M., Broda, G., Cesana, G., Dallongeville, J., Ducimetriere, P., Evans, A., Ferrieres, J., Haas, B., Jorgensen, T., Tamosiunas, A., Vanuzzo, D., Wiklund, P.G., Yarnell, J., Kuulasmaa, K., Kulathinal, S., Relative risks for stroke by age, sex, and population based on follow-up of 18 European populations in the MORGAM Project. Stroke 40 (2009), 2319–2326.
7. Bacigaluppi, M., Pluchino, S., Martino, G., Kilic, E., Hermann, D.M., Neural stem/precursor cells for the treatment of ischemic stroke. J. Neurol. Sci. 265 (2008), 73–77.
8. Badan, I., Buchhold, B., Hamm, A., Gratz, M., Walker, L.C., Platt, D., Kessler, C., Popa-Wagner, A., Accelerated glial reactivity to stroke in aged rats correlates with reduced functional recovery. J. Cereb. Blood Flow Metab. 23 (2003), 845–854.
9. Bae, J.S., Han, H.S., Youn, D.H., Carter, J.E., Modo, M., Schuchman, E.H., Jin, H.K., Bone marrow-derived mesenchymal stem cells promote neuronal networks with functional synaptic transmission after transplantation into mice with neurodegeneration. Stem Cells (Dayton Ohio) 25 (2007), 1307–1316.
10. Baker, A.H., Sica, V., Work, L.M., Williams-Ignarro, S., de Nigris, F., Lerman, L.O., Casamassimi, A., Lanza, A., Schiano, C., Rienzo, M., Ignarro, L.J., Napoli, C., Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 3597–3602.
11. Banerjee, S., Bentley, P., Hamady, M., Marley, S., Davis, J., Shlebak, A., Nicholls, J., Williamson, D.A., Jensen, S.L., Gordon, M., Habib, N., Chataway, J., Intra-arterial immunoselected CD34+ stem cells for acute ischemic stroke. Stem Cells Transl. Med. 3 (2014), 1322–1330.
12. Bao, X., Wei, J., Feng, M., Lu, S., Li, G., Dou, W., Ma, W., Ma, S., An, Y., Qin, C., Zhao, R.C., Wang, R., Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats. Brain Res. 1367 (2011), 103–113.
13. Behari, M., Singhal, K.K., Cell based therapies in Parkinson's disease. Ann. Neurosci. 18 (2011), 76–83.
14. Belenguer, G., Domingo-Muelas, A., Ferron, S.R., Morante-Redolat, J.M., Farinas, I., Isolation, culture and analysis of adult subependymal neural stem cells. Differentiation, 2016.
15. Bell, R.D., Zlokovic, B.V., Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol. 118 (2009), 103–113.
16. Berninger, B., Costa, M.R., Koch, U., Schroeder, T., Sutor, B., Grothe, B., Gotz, M., Functional properties of neurons derived from in vitro reprogrammed postnatal astroglia. J. Neurosci. 27 (2007), 8654–8664.
17. Bhasin, A., Srivastava, M.V., Mohanty, S., Bhatia, R., Kumaran, S.S., Bose, S., Stem cell therapy: a clinical trial of stroke. Clin. Neurol. Neurosurg. 115 (2013), 1003–1008.
18. Blanco, Y., Saiz, A., Carreras, E., Graus, F., Autologous haematopoietic-stem-cell transplantation for multiple sclerosis. Lancet Neurol. 4 (2005), 54–63.
19. Bliss, T.M., Andres, R.H., Steinberg, G.K., Optimizing the success of cell transplantation therapy for stroke. Neurobiol. Dis. 37 (2010), 275–283.
20. Blum, R., Heinrich, C., Sanchez, R., Lepier, A., Gundelfinger, E.D., Berninger, B., Gotz, M., Neuronal network formation from reprogrammed early postnatal rat cortical glial cells. Cereb. Cortex 21 (2011), 413–424.
21. Blurton-Jones, M., Spencer, B., Michael, S., Castello, N.A., Agazaryan, A.A., Davis, J.L., Muller, F.J., Loring, J.F., Masliah, E., LaFerla, F.M., Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models. Stem Cell Res. Ther., 5, 2014, 46.
22. Bond, A.M., Ming, G.L., Song, H., Adult mammalian neural stem cells and neurogenesis: five decades later. Cell Stem Cell 17 (2015), 385–395.
23. Bourin, P., Bunnell, B.A., Casteilla, L., Dominici, M., Katz, A.J., March, K.L., Redl, H., Rubin, J.P., Yoshimura, K., Gimble, J.M., Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 15 (2013), 641–648.
24. Braak, H., Del Tredici, K., Rub, U., de Vos, R.A., Jansen Steur, E.N., Braak, E., Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24 (2003), 197–211.
25. Bredesen, D.E., Rao, R.V., Mehlen, P., Cell death in the nervous system. Nature 443 (2006), 796–802.
26. Brenneman, M., Sharma, S., Harting, M., Strong, R., Cox, C.S. Jr., Aronowski, J., Grotta, J.C., Savitz, S.I., Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J. Cereb. Blood Flow Metab. 30 (2010), 140–149.
27. Brignier, A.C., Gewirtz, A.M., Embryonic and adult stem cell therapy. J. Allergy Clin. Immunol. 125 (2010), S336–344.
28. Buddhala, C., Loftin, S.K., Kuley, B.M., Cairns, N.J., Campbell, M.C., Perlmutter, J.S., Kotzbauer, P.T., Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease. Ann. Clin. Transl. Neurol. 2 (2015), 949–959.
29. Burzynska, A.Z., Preuschhof, C., Backman, L., Nyberg, L., Li, S.C., Lindenberger, U., Heekeren, H.R., Age-related differences in white matter microstructure: region-specific patterns of diffusivity. Neuroimage 49 (2010), 2104–2112.
30. Carson, C.T., Aigner, S., Gage, F.H., Stem cells: the good, bad and barely in control. Nat. Med. 12 (2006), 1237–1238.
31. Cave, J.W., Baker, H., Dopamine systems in the forebrain. Adv. Exp. Med. Biol. 651 (2009), 15–35.
32. Cave, J.W., Wang, M., Baker, H., Adult subventricular zone neural stem cells as a potential source of dopaminergic replacement neurons. Front. Neurosci., 8, 2014, 16.
33. Chan, T.M., Chen, J.Y., Ho, L.I., Lin, H.P., Hsueh, K.W., Liu, D.D., Chen, Y.H., Hsieh, A.C., Tsai, N.M., Hueng, D.Y., Tsai, S.T., Chou, P.W., Lin, S.Z., Harn, H.J., ADSC therapy in neurodegenerative disorders. Cell Transplant. 23 (2014), 549–557.
34. Chan, T.M., Harn, H.J., Lin, H.P., Chiu, S.C., Lin, P.C., Wang, H.I., Ho, L.I., Chuu, C.P., Chiou, T.W., Hsieh, A.C., Chen, Y.W., Ho, W.Y., Lin, S.Z., The use of ADSCs as a treatment for chronic stroke. Cell Transplant. 23 (2014), 541–547.
35. Chao, Y.H., Wu, H.P., Chan, C.K., Tsai, C., Peng, C.T., Wu, K.H., Umbilical cord-derived mesenchymal stem cells for hematopoietic stem cell transplantation. J. Biomed. Biotechnol., 2012, 2012, 759503.
36. Chapman, C.D., Frey, W.H., 2nd Craft, S., Danielyan, L., Hallschmid, M., Schioth, H.B., Benedict, C., Intranasal treatment of central nervous system dysfunction in humans. Pharm. Res. 30 (2013), 2475–2484.
37. Chartoff, E.H., Damez-Werno, D., Sonntag, K.C., Hassinger, L., Kaufmann, D.E., Peterson, J., McPhie, D., Cataldo, A.M., Cohen, B.M., Detection of intranasally delivered bone marrow-derived mesenchymal stromal cells in the lesioned mouse brain: a cautionary report. Stem Cells Int., 2011, 2011, 586586.
38. Chen, Y., Sun, F.Y., Age-related decrease of striatal neurogenesis is associated with apoptosis of neural precursors and newborn neurons in rat brain after ischemia. Brain Res. 1166 (2007), 9–19.
39. Chen, L., Xi, H., Huang, H., Zhang, F., Liu, Y., Chen, D., Xiao, J., Multiple cell transplantation based on an intraparenchymal approach for patients with chronic phase stroke. Cell Transplant. 22:Suppl. 1 (2013), S83–91.
40. Chen, D.C., Lin, S.Z., Fan, J.R., Lin, C.H., Lee, W., Lin, C.C., Liu, Y.J., Tsai, C.H., Chen, J.C., Cho, D.Y., Lee, C.C., Shyu, W.C., Intracerebral implantation of autologous peripheral blood stem cells in stroke patients: a randomized phase II study. Cell Transplant. 23 (2014), 1599–1612.
41. Chen, J., Venkat, P., Zacharek, A., Chopp, M., Neurorestorative therapy for stroke. Front. Hum. Neurosci., 8, 2014, 382.
42. Chen, S.Q., Cai, Q., Shen, Y.Y., Wang, P.Y., Li, M.H., Teng, G.Y., Neural stem cell transplantation improves spatial learning and memory via neuronal regeneration in amyloid-beta precursor protein/presenilin 1/tau triple transgenic mice. Am. J. Alzheimers Dis. Other Demen. 29 (2014), 142–149.
43. Cheng, H.C., Ulane, C.M., Burke, R.E., Clinical progression in Parkinson disease and the neurobiology of axons. Ann. Neurol. 67 (2010), 715–725.
44. Cheng, Q., Zhang, Z., Zhang, S., Yang, H., Zhang, X., Pan, J., Weng, L., Sha, D., Zhu, M., Hu, X., Xu, Y., Human umbilical cord mesenchymal stem cells protect against ischemic brain injury in mouse by regulating peripheral immunoinflammation. Brain Res. 1594 (2015), 293–304.
45. Chiu, A.Y., Hall, Z.W., Stem cell research: the California experience. J. Neurosci. 26 (2006), 6661–6663.
46. Chiu, A.Y., Rao, M.S., Cell-based therapy for neural disorders–anticipating challenges. Neurotherapeutics 8 (2011), 744–752.
47. Chua, J.Y., Pendharkar, A.V., Wang, N., Choi, R., Andres, R.H., Gaeta, X., Zhang, J., Moseley, M.E., Guzman, R., Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes. J. Cereb. Blood Flow Metab. 31 (2011), 1263–1271.
48. Chung, C.S., Fujita, N., Kawahara, N., Yui, S., Nam, E., Nishimura, R., A comparison of neurosphere differentiation potential of canine bone marrow-derived mesenchymal stem cells and adipose-derived mesenchymal stem cells. J. Vet. Med. Sci. 75 (2013), 879–886.
49. Corbett, D., Nguemeni, C., Gomez-Smith, M., How can you mend a broken brain? Neurorestorative approaches to stroke recovery. Cerebrovasc. Dis. 38 (2014), 233–239.
50. Dalous, J., Larghero, J., Baud, O., Transplantation of umbilical cord-derived mesenchymal stem cells as a novel strategy to protect the central nervous system: technical aspects, preclinical studies, and clinical perspectives. Pediatr. Res. 71 (2012), 482–490.
51. Ding, D.C., Lin, C.H., Shyu, W.C., Lin, S.Z., Neural stem cells and stroke. Cell Transplant. 22 (2013), 619–630.
52. Dong, P., Zhao, J., Zhang, Y., Dong, J., Zhang, L., Li, D., Li, L., Zhang, X., Yang, B., Lei, W., Aging causes exacerbated ischemic brain injury and failure of sevoflurane post-conditioning: role of B-cell lymphoma-2. Neuroscience 275 (2014), 2–11.
53. Donnellan, C., Hevey, D., Hickey, A., O'Neill, D., Adaptation to stroke using a model of successful aging. Neuropsychol. Dev. Cogn. B 19 (2012), 530–547.
54. Drouin-Ouellet, J., Barker, R.A., Stem cell therapies for Parkinson's disease: are trials just around the corner?. Regen. Med. 9 (2014), 553–555.
55. Du, G., Liu, Y., Dang, M., Zhu, G., Su, R., Fan, Y., Tan, Z., Wang, L.X., Fang, J., Comparison of administration routes for adipose-derived stem cells in the treatment of middle cerebral artery occlusion in rats. Acta Histochem. 116 (2014), 1075–1084.
56. Epstein, J.B., Raber-Durlacher, J.E., Wilkins, A., Chavarria, M.G., Myint, H., Advances in hematologic stem cell transplant: an update for oral health care providers. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 107 (2009), 301–312.
57. Fjell, A.M., Westlye, L.T., Grydeland, H., Amlien, I., Espeseth, T., Reinvang, I., Raz, N., Dale, A.M., Walhovd, K.B., Accelerating cortical thinning: unique to dementia or universal in aging?. Cereb. Cortex 24 (2014), 919–934.
58. Garcia, K.O., Ornellas, F.L., Martin, P.K., Patti, C.L., Mello, L.E., Frussa-Filho, R., Han, S.W., Longo, B.M., Therapeutic effects of the transplantation of VEGF overexpressing bone marrow mesenchymal stem cells in the hippocampus of murine model of Alzheimer's disease. Front. Aging Neurosci., 6, 2014, 30.
59. Glat, M.J., Offen, D., Cell and gene therapy in Alzheimer's disease. Stem Cells Dev. 22 (2013), 1490–1496.
60. Goedert, M., Alpha-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci. 2 (2001), 492–501.
61. Good, C.D., Johnsrude, I.S., Ashburner, J., Henson, R.N., Friston, K.J., Frackowiak, R.S., A voxel-based morphometric study of aging in 465 normal adult human brains. Neuroimage 14 (2001), 21–36.
62. Gross, R.E., Watts, R.L., Hauser, R.A., Bakay, R.A., Reichmann, H., von Kummer, R., Ondo, W.G., Reissig, E., Eisner, W., Steiner-Schulze, H., Siedentop, H., Fichte, K., Hong, W., Cornfeldt, M., Beebe, K., Sandbrink, R., Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomized, controlled trial. Lancet Neurol. 10 (2011), 509–519.
63. Guo, Z., Zhang, L., Wu, Z., Chen, Y., Wang, F., Chen, G., In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer's disease model. Cell Stem Cell 14 (2014), 188–202.
64. Gutierrez-Fernandez, M., Rodriguez-Frutos, B., Ramos-Cejudo, J., Teresa Vallejo-Cremades, M., Fuentes, B., Cerdan, S., Diez-Tejedor, E., Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Stem Cell Res. Ther., 4, 2013, 11.
65. Gutierrez-Fernandez, M., Otero-Ortega, L., Ramos-Cejudo, J., Rodriguez-Frutos, B., Fuentes, B., Diez-Tejedor, E., Adipose tissue-derived mesenchymal stem cells as a strategy to improve recovery after stroke. Expert Opin. Biol. Ther. 15 (2015), 873–881.
66. Halliday, G.M., McCann, H., The progression of pathology in Parkinson's disease. Ann. N. Y. Acad. Sci. 1184 (2010), 188–195.
67. Han, F., Baremberg, D., Gao, J., Duan, J., Lu, X., Zhang, N., Chen, Q., Development of stem cell-based therapy for Parkinson's disease. Transl. Neurodegener, 4, 2015, 16.
68. Hanley, J., Rastegarlari, G., Nathwani, A.C., An introduction to induced pluripotent stem cells. Br. J. Haematol. 151 (2010), 16–24.
69. Harris, L., Zalucki, O., Piper, M., Heng, J.I., Insights into the biology and therapeutic applications of neural stem cells. Stem Cells Int., 2016, 2016, 9745315.
70. He, L.Q., Lu, J.H., Yue, Z.Y., Autophagy in aging and aging-associated diseases. Acta Pharmacol. Sin. 34 (2013), 605–611.
71. Hebert, L.E., Weuve, J., Scherr, P.A., Evans, D.A., Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology 80 (2013), 1778–1783.
72. Heinrich, C., Gascon, S., Masserdotti, G., Lepier, A., Sanchez, R., Simon-Ebert, T., Schroeder, T., Gotz, M., Berninger, B., Generation of subtype-specific neurons from postnatal astroglia of the mouse cerebral cortex. Nat. Protoc. 6 (2011), 214–228.
73. Henningson, C.T. Jr., Stanislaus, M.A., Gewirtz, A.M., 28: Embryonic and adult stem cell therapy. J. Allergy Clin. Immunol. 111 (2003), S745–753.
74. Hilfiker, A., Kasper, C., Hass, R., Haverich, A., Mesenchymal stem cells and progenitor cells in connective tissue engineering and regenerative medicine: is there a future for transplantation?. Langenbecks Arch. Surg. 396 (2011), 489–497.
75. Hindle, J.V., Ageing, neurodegeneration and Parkinson's disease. Age Ageing 39 (2010), 156–161.
76. Hoyte, L., Kaur, J., Buchan, A.M., Lost in translation: taking neuroprotection from animal models to clinical trials. Exp. Neurol. 188 (2004), 200–204.
77. Huang, Y., Mucke, L., Alzheimer mechanisms and therapeutic strategies. Cell 148 (2012), 1204–1222.
78. Hung, S.C., Pochampally, R.R., Chen, S.C., Hsu, S.C., Prockop, D.J., Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells 25 (2007), 2363–2370.
79. Hung, C.W., Chen, Y.C., Hsieh, W.L., Chiou, S.H., Kao, C.L., Ageing and neurodegenerative diseases. Ageing Res. Rev. 9:Suppl. 1 (2010), S36–46.
80. Hunsberger, J.G., Rao, M., Kurtzberg, J., Bulte, J.W., Atala, A., LaFerla, F.M., Greely, H.T., Sawa, A., Gandy, S., Schneider, L.S., Doraiswamy, P.M., Accelerating stem cell trials for Alzheimer's disease. Lancet Neurol., 2015.
81. Ikegame, Y., Yamashita, K., Hayashi, S., Mizuno, H., Tawada, M., You, F., Yamada, K., Tanaka, Y., Egashira, Y., Nakashima, S., Yoshimura, S., Iwama, T., Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy 13 (2011), 675–685.
82. Isobe, K., Cheng, Z., Nishio, N., Suganya, T., Tanaka, Y., Ito, S., iPSCs, aging and age-related diseases. N Biotechnol. 31 (2014), 411–421.
83. Iwai, M., Cao, G., Yin, W., Stetler, R.A., Liu, J., Chen, J., Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats. Stroke 38 (2007), 2795–2803.
84. Jiang, M., Lv, L., Ji, H., Yang, X., Zhu, W., Cai, L., Gu, X., Chai, C., Huang, S., Sun, J., Dong, Q., Induction of pluripotent stem cells transplantation therapy for ischemic stroke. Mol. Cell. Biochem. 354 (2011), 67–75.
85. Jiang, Y., Zhu, W., Zhu, J., Wu, L., Xu, G., Liu, X., Feasibility of delivering mesenchymal stem cells via catheter to the proximal end of the lesion artery in patients with stroke in the territory of the middle cerebral artery. Cell Transplant. 22 (2013), 2291–2298.
86. Jinno, S., Aging affects new cell production in the adult hippocampus: a quantitative anatomic review. J. Chem. Neuroanat., 2015.
87. Kan, I., Melamed, E., Offen, D., Autotransplantation of bone marrow-derived stem cells as a therapy for neurodegenerative diseases. Handb. Exp. Pharmacol., 2007, 219–242.
88. Kan, I., Barhum, Y., Melamed, E., Offen, D., Mesenchymal stem cells stimulate endogenous neurogenesis in the subventricular zone of adult mice. Stem Cell Rev. 7 (2011), 404–412.
89. Karussis, D., Petrou, P., Kassis, I., Clinical experience with stem cells and other cell therapies in neurological diseases. J. Neurol. Sci. 324 (2013), 1–9.
90. Kazmerova, Z., Zilka, N., Cente, M., Neradil, P., Zilkova, M., Novak, M., Can we teach old dogs new tricks? Neuroprotective cell therapy in Alzheimer's and Parkinson's disease. J. Alzheimers Dis. 37 (2013), 251–272.
91. Kim, D.Y., Park, S.H., Lee, S.U., Choi, D.H., Park, H.W., Paek, S.H., Shin, H.Y., Kim, E.Y., Park, S.P., Lim, J.H., Effect of human embryonic stem cell-derived neuronal precursor cell transplantation into the cerebral infarct model of rat with exercise. Neurosci. Res. 58 (2007), 164–175.
92. Kim, S., Chang, K.A., Kim, J., Park, H.G., Ra, J.C., Kim, H.S., Suh, Y.H., The preventive and therapeutic effects of intravenous human adipose-derived stem cells in Alzheimer's disease mice. PLoS One, 7, 2012, e45757.
93. Kim, S.J., Moon, G.J., Chang, W.H., Kim, Y.H., Bang, O.Y., Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial. Trials, 14, 2013, 317.
94. Kim, J., Kim, S.J., Naka, K., Transcriptome sequencing of hematopoietic stem cells and chronic myelgenous leukemia stem cells. Genomics Data 7 (2016), 57–59.
95. Kinnaird, T., Stabile, E., Burnett, M.S., Shou, M., Lee, C.W., Barr, S., Fuchs, S., Epstein, S.E., Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109 (2004), 1543–1549.
96. Koh, S.H., Kim, K.S., Choi, M.R., Jung, K.H., Park, K.S., Chai, Y.G., Roh, W., Hwang, S.J., Ko, H.J., Huh, Y.M., Kim, H.T., Kim, S.H., Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res. 1229 (2008), 233–248.
97. Kokai, L.E., Marra, K., Rubin, J.P., Adipose stem cells: biology and clinical applications for tissue repair and regeneration. Transl. Res. 163 (2014), 399–408.
98. Kondziolka, D., Wechsler, L., Goldstein, S., Meltzer, C., Thulborn, K.R., Gebel, J., Jannetta, P., DeCesare, S., Elder, E.M., McGrogan, M., Reitman, M.A., Bynum, L., Transplantation of cultured human neuronal cells for patients with stroke. Neurology 55 (2000), 565–569.
99. Kondziolka, D., Steinberg, G.K., Wechsler, L., Meltzer, C.C., Elder, E., Gebel, J., Decesare, S., Jovin, T., Zafonte, R., Lebowitz, J., Flickinger, J.C., Tong, D., Marks, M.P., Jamieson, C., Luu, D., Bell-Stephens, T., Teraoka, J., Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J. Neurosurg. 103 (2005), 38–45.
100. Krause, D.S., Theise, N.D., Collector, M.I., Henegariu, O., Hwang, S., Gardner, R., Neutzel, S., Sharkis, S.J., Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105 (2001), 369–377.
101. Lanni, C., Stanga, S., Racchi, M., Govoni, S., The expanding universe of neurotrophic factors: therapeutic potential in aging and age-associated disorders. Curr. Pharm. Des. 16 (2010), 698–717.
102. Leak, R.K., Zheng, P., Ji, X., Zhang, J.H., Chen, J., From apoplexy to stroke: historical perspectives and new research frontiers. Prog. Neurobiol. 115 (2014), 1–5.
103. Lee, J.K., Jin, H.K., Bae, J.S., Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model. Neurosci. Lett. 450 (2009), 136–141.
104. Lee, H.J., Lee, J.K., Lee, H., Shin, J.W., Carter, J.E., Sakamoto, T., Jin, H.K., Bae, J.S., The therapeutic potential of human umbilical cord blood-derived mesenchymal stem cells in Alzheimer's disease. Neurosci. Lett. 481 (2010), 30–35.
105. Lee, J.K., Jin, H.K., Endo, S., Schuchman, E.H., Carter, J.E., Bae, J.S., Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses. Stem Cells 28 (2010), 329–343.
106. Lee, J.K., Schuchman, E.H., Jin, H.K., Bae, J.S., Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid beta ameliorates Alzheimer's disease in mice by recruiting bone marrow-induced microglia immune responses. Stem Cells 30 (2012), 1544–1555.
107. Li, L., Jiang, Q., Ding, G., Zhang, L., Zhang, Z.G., Li, Q., Panda, S., Lu, M., Ewing, J.R., Chopp, M., Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study. J. Cereb. Blood Flow Metab. 30 (2010), 653–662.
108. Li, Y.H., Feng, L., Zhang, G.X., Ma, C.G., Intranasal delivery of stem cells as therapy for central nervous system disease. Exp. Mol. Pathol. 98 (2015), 145–151.
109. Liao, W., Xie, J., Zhong, J., Liu, Y., Du, L., Zhou, B., Xu, J., Liu, P., Yang, S., Wang, J., Han, Z., Han, Z.C., Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Transplantation 87 (2009), 350–359.
110. Liao, W., Zhong, J., Yu, J., Xie, J., Liu, Y., Du, L., Yang, S., Liu, P., Xu, J., Wang, J., Han, Z., Han, Z.C., Therapeutic benefit of human umbilical cord derived mesenchymal stromal cells in intracerebral hemorrhage rat: implications of anti-inflammation and angiogenesis. Cell. Physiol. Biochem. 24 (2009), 307–316.
111. Lindroos, B., Suuronen, R., Miettinen, S., The potential of adipose stem cells in regenerative medicine. Stem Cell Rev. 7 (2011), 269–291.
112. Liu, X., Ye, R., Yan, T., Yu, S.P., Wei, L., Xu, G., Fan, X., Jiang, Y., Stetler, R.A., Liu, G., Chen, J., Cell based therapies for ischemic stroke: from basic science to bedside. Prog. Neurobiol. 115 (2014), 92–115.
113. Lochhead, J.J., Thorne, R.G., Intranasal delivery of biologics to the central nervous system. Adv. Drug Deliv. Rev. 64 (2012), 614–628.
114. Ma, T., Gong, K., Ao, Q., Yan, Y., Song, B., Huang, H., Zhang, X., Gong, Y., Intracerebral transplantation of adipose-derived mesenchymal stem cells alternatively activates microglia and ameliorates neuropathological deficits in Alzheimer's disease mice. Cell Transplant. 22:Suppl. 1 (2013), S113–126.
115. Marner, L., Nyengaard, J.R., Tang, Y., Pakkenberg, B., Marked loss of myelinated nerve fibers in the human brain with age. J. Comp. Neurol. 462 (2003), 144–152.
116. Martinez-Morales, P.L., Revilla, A., Ocana, I., Gonzalez, C., Sainz, P., McGuire, D., Liste, I., Progress in stem cell therapy for major human neurological disorders. Stem Cell Rev. 9 (2013), 685–699.
117. Matsumoto, T., Fujimori, K., Andoh-Noda, T., Ando, T., Kuzumaki, N., Toyoshima, M., Tada, H., Imaizumi, K., Ishikawa, M., Yamaguchi, R., Isoda, M., Zhou, Z., Sato, S., Kobayashi, T., Ohtaka, M., Nishimura, K., Kurosawa, H., Yoshikawa, T., Takahashi, T., Nakanishi, M., Ohyama, M., Hattori, N., Akamatsu, W., Okano, H., Functional neurons generated from T cell-derived induced pluripotent stem cells for neurological disease modeling. Stem Cell Rep. 6 (2016), 422–435.
118. Merceron, C., Portron, S., Masson, M., Lesoeur, J., Fellah, B.H., Gauthier, O., Geffroy, O., Weiss, P., Guicheux, J., Vinatier, C., The effect of two- and three-dimensional cell culture on the chondrogenic potential of human adipose-derived mesenchymal stem cells after subcutaneous transplantation with an injectable hydrogel. Cell Transplant. 20 (2011), 1575–1588.
119. Ming, G.L., Song, H., Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron 70 (2011), 687–702.
120. Misra, V., Ritchie, M.M., Stone, L.L., Low, W.C., Janardhan, V., Stem cell therapy in ischemic stroke: role of IV and intra-arterial therapy. Neurology 79 (2012), S207–212.
121. Montarras, D., Morgan, J., Collins, C., Relaix, F., Zaffran, S., Cumano, A., Partridge, T., Buckingham, M., Direct isolation of satellite cells for skeletal muscle regeneration. Science 309 (2005), 2064–2067.
122. Montine, T.J., Phelps, C.H., Beach, T.G., Bigio, E.H., Cairns, N.J., Dickson, D.W., Duyckaerts, C., Frosch, M.P., Masliah, E., Mirra, S.S., Nelson, P.T., Schneider, J.A., Thal, D.R., Trojanowski, J.Q., Vinters, H.V., Hyman, B.T., National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol. 123 (2012), 1–11.
123. Mungas, D., Tractenberg, R., Schneider, J.A., Crane, P.K., Bennett, D.A., A 2-process model for neuropathology of Alzheimer's disease. Neurobiol. Aging 35 (2014), 301–308.
124. Nam, H., Lee, K.H., Nam, D.H., Joo, K.M., Adult human neural stem cell therapeutics: current developmental status and prospect. World J. Stem Cells 7 (2015), 126–136.
125. Niu, W., Zang, T., Zou, Y., Fang, S., Smith, D.K., Bachoo, R., Zhang, C.L., In vivo reprogramming of astrocytes to neuroblasts in the adult brain. Nat. Cell Biol. 15 (2013), 1164–1175.
126. Ohab, J.J., Fleming, S., Blesch, A., Carmichael, S.T., A neurovascular niche for neurogenesis after stroke. J. Neurosci. 26 (2006), 13007–13016.
127. Ohta, K., Iwai, M., Sato, K., Omori, N., Nagano, I., Shoji, M., Abe, K., Dissociative increase of oligodendrocyte progenitor cells between young and aged rats after transient cerebral ischemia. Neurosci. Lett. 335 (2003), 159–162.
128. Ong, W.K., Sugii, S., Adipose-derived stem cells: fatty potentials for therapy. Int. J. Biochem. Cell Biol. 45 (2013), 1083–1086.
129. Orio, F., Muscogiuri, G., Palomba, S., Serio, B., Sessa, M., Giudice, V., Ferrara, I., Tauchmanova, L., Colao, A., Selleri, C., Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. ScientificWorldJournal, 2014, 2014, 282147.
130. Oyamada, N., Itoh, H., Sone, M., Yamahara, K., Miyashita, K., Park, K., Taura, D., Inuzuka, M., Sonoyama, T., Tsujimoto, H., Fukunaga, Y., Tamura, N., Nakao, K., Transplantation of vascular cells derived from human embryonic stem cells contributes to vascular regeneration after stroke in mice. J. Transl. Med., 6, 2008, 54.
131. Pak, J., Lee, J.H., Kartolo, W.A., Lee, S.H., Cartilage regeneration in human with adipose tissue-derived stem cells: current status in clinical implications. BioMed Res. Int., 2016, 2016, 4702674.
132. Pakkenberg, B., Pelvig, D., Marner, L., Bundgaard, M.J., Gundersen, H.J., Nyengaard, J.R., Regeur, L., Aging and the human neocortex. Exp. Gerontol. 38 (2003), 95–99.
133. Pekny, M., Nilsson, M., Astrocyte activation and reactive gliosis. Glia 50 (2005), 427–434.
134. Popa-Wagner, A., Dinca, I., Yalikun, S., Walker, L., Kroemer, H., Kessler, C., Accelerated delimitation of the infarct zone by capillary-derived nestin-positive cells in aged rats. Curr. Neurovasc. Res. 3 (2006), 3–13.
135. Popa-Wagner, A., Badan, I., Walker, L., Groppa, S., Patrana, N., Kessler, C., Accelerated infarct development, cytogenesis and apoptosis following transient cerebral ischemia in aged rats. Acta Neuropathol. 113 (2007), 277–293.
136. Prasad, K., Mohanty, S., Bhatia, R., Srivastava, M.V., Garg, A., Srivastava, A., Goyal, V., Tripathi, M., Kumar, A., Bal, C., Vij, A., Mishra, N.K., Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: a pilot study. Indian J. Med. Res. 136 (2012), 221–228.
137. Prasad, K., Sharma, A., Garg, A., Mohanty, S., Bhatnagar, S., Johri, S., Singh, K.K., Nair, V., Sarkar, R.S., Gorthi, S.P., Hassan, K.M., Prabhakar, S., Marwaha, N., Khandelwal, N., Misra, U.K., Kalita, J., Nityanand, S., Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial. Stroke 45 (2014), 3618–3624.
138. Qiao, L.Y., Huang, F.J., Zhao, M., Xie, J.H., Shi, J., Wang, J., Lin, X.Z., Zuo, H., Wang, Y.L., Geng, T.C., A two-year follow-up study of cotransplantation with neural stem/progenitor cells and mesenchymal stromal cells in ischemic stroke patients. Cell Transplant. 23:Suppl. 1 (2014), S65–72.
139. Rabinovich, S.S., Seledtsov, V.I., Banul, N.V., Poveshchenko, O.V., Senyukov, V.V., Astrakov, S.V., Samarin, D.M., Taraban, V.Y., Cell therapy of brain stroke. Bull. Exp. Biol. Med. 139 (2005), 126–128.
140. Rafalski, V.A., Brunet, A., Energy metabolism in adult neural stem cell fate. Prog. Neurobiol. 93 (2011), 182–203.
141. Razavi, S., Razavi, M.R., Zarkesh Esfahani, H., Kazemi, M., Mostafavi, F.S., Comparing brain-derived neurotrophic factor and ciliary neurotrophic factor secretion of induced neurotrophic factor secreting cells from human adipose and bone marrow-derived stem cells. Dev. Growth Differ. 55 (2013), 648–655.
142. Reddy, P.H., Tripathi, R., Troung, Q., Tirumala, K., Reddy, T.P., Anekonda, V., Shirendeb, U.P., Calkins, M.J., Reddy, A.P., Mao, P., Manczak, M., Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. Biochim. Biophys. Acta 1822 (2012), 639–649.
143. Robel, S., Berninger, B., Gotz, M., The stem cell potential of glia: lessons from reactive gliosis. Nat. Rev. Neurosci. 12 (2011), 88–104.
144. Roger, V.L., Go, A.S., Lloyd-Jones, D.M., Benjamin, E.J., Berry, J.D., Borden, W.B., Bravata, D.M., Dai, S., Ford, E.S., Fox, C.S., Fullerton, H.J., Gillespie, C., Hailpern, S.M., Heit, J.A., Howard, V.J., Kissela, B.M., Kittner, S.J., Lackland, D.T., Lichtman, J.H., Lisabeth, L.D., Makuc, D.M., Marcus, G.M., Marelli, A., Matchar, D.B., Moy, C.S., Mozaffarian, D., Mussolino, M.E., Nichol, G., Paynter, N.P., Soliman, E.Z., Sorlie, P.D., Sotoodehnia, N., Turan, T.N., Virani, S.S., Wong, N.D., Woo, D., Turner, M.B., Heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation 125 (2012), e2–e220.
145. Roozbehi, A., Joghataei, M.T., Bakhtiyari, M., Mohammadi, J., Rad, P., Delaviz, H., Age-associated changes on axonal regeneration and functional outcome after spinal cord injury in rats. Acta Med. Iran. 53 (2015), 281–286.
146. Sadan, O., Melamed, E., Offen, D., Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases. Expert Opin. Biol. Ther. 9 (2009), 1487–1497.
147. Sadan, O., Shemesh, N., Cohen, Y., Melamed, E., Offen, D., Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases. Isr. Med. Assoc. J. 11 (2009), 201–204.
148. Sahin, E., Depinho, R.A., Linking functional decline of telomeres, mitochondria and stem cells during aging. Nature 464 (2010), 520–528.
149. Salem, A.M., Ahmed, H.H., Atta, H.M., Ghazy, M.A., Aglan, H.A., Potential of bone marrow mesenchymal stem cells in management of Alzheimer's disease in female rats. Cell Biol. Int. 38 (2014), 1367–1383.
150. Sanchez-Ramos, J.R., Neural cells derived from adult bone marrow and umbilical cord blood. J. Neurosci. Res. 69 (2002), 880–893.
151. Savitz, S.I., Dinsmore, J.H., Wechsler, L.R., Rosenbaum, D.M., Caplan, L.R., Cell therapy for stroke. NeuroRx 1 (2004), 406–414.
152. Savitz, S.I., Dinsmore, J., Wu, J., Henderson, G.V., Stieg, P., Caplan, L.R., Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovasc. Dis. (Basel Switzerland) 20 (2005), 101–107.
153. Schapira, A.H., Agid, Y., Barone, P., Jenner, P., Lemke, M.R., Poewe, W., Rascol, O., Reichmann, H., Tolosa, E., Perspectives on recent advances in the understanding and treatment of Parkinson's disease. Eur. J. Neurol. 16 (2009), 1090–1099.
154. Schneider, S.A., Obeso, J.A., Clinical and pathological features of Parkinson's disease. Curr. Top. Behav. Neurosci. 22 (2015), 205–220.
155. Shen, L.H., Li, Y., Gao, Q., Savant-Bhonsale, S., Chopp, M., Down-regulation of neurocan expression in reactive astrocytes promotes axonal regeneration and facilitates the neurorestorative effects of bone marrow stromal cells in the ischemic rat brain. Glia 56 (2008), 1747–1754.
156. Shetty, P., Thakur, A.M., Viswanathan, C., Dopaminergic cells, derived from a high efficiency differentiation protocol from umbilical cord derived mesenchymal stem cells, alleviate symptoms in a Parkinson's disease rodent model. Cell Biol. Int. 37 (2013), 167–180.
157. Shin, J.W., Lee, J.K., Lee, J.E., Min, W.K., Schuchman, E.H., Jin, H.K., Bae, J.S., Combined effects of hematopoietic progenitor cell mobilization from bone marrow by granulocyte colony stimulating factor and AMD3100 and chemotaxis into the brain using stromal cell-derived factor-1alpha in an Alzheimer's disease mouse model. Stem Cells (Dayton Ohio) 29 (2011), 1075–1089.
158. Shuaib, A., Boyle, C., Stroke in the elderly. Curr. Opin. Neurol. 7 (1994), 41–47.
159. Singh, N., Pillay, V., Choonara, Y.E., Advances in the treatment of Parkinson's disease. Prog. Neurobiol. 81 (2007), 29–44.
160. Sobrino, T., Arias, S., Perez-Mato, M., Agulla, J., Brea, D., Rodriguez-Yanez, M., Castillo, J., Cd34+ progenitor cells likely are involved in the good functional recovery after intracerebral hemorrhage in humans. J. Neurosci. Res. 89 (2011), 979–985.
161. Spits, C., Mateizel, I., Geens, M., Mertzanidou, A., Staessen, C., Vandeskelde, Y., Van der Elst, J., Liebaers, I., Sermon, K., Recurrent chromosomal abnormalities in human embryonic stem cells. Nat. Biotechnol. 26 (2008), 1361–1363.
162. Sproul, A.A., Being human: the role of pluripotent stem cells in regenerative medicine and humanizing Alzheimer's disease models. Mol. Aspects Med. 43–44 (2015), 54–65.
163. Sugaya, K., Possible use of autologous stem cell therapies for Alzheimer's disease. Curr. Alzheimer Res. 2 (2005), 367–376.
164. Sugii, S., Kida, Y., Berggren, W.T., Evans, R.M., Feeder-dependent and feeder-independent iPS cell derivation from human and mouse adipose stem cells. Nat. Protoc. 6 (2011), 346–358.
165. Suon, S., Yang, M., Iacovitti, L., Adult human bone marrow stromal spheres express neuronal traits in vitro and in a rat model of Parkinson's disease. Brain Res. 1106 (2006), 46–51.
166. Taguchi, A., Sakai, C., Soma, T., Kasahara, Y., Stern, D.M., Kajimoto, K., Ihara, M., Daimon, T., Yamahara, K., Doi, K., Kohara, N., Nishimura, H., Matsuyama, T., Naritomi, H., Sakai, N., Nagatsuka, K., Intravenous autologous bone marrow mononuclear cell transplantation for stroke: phase1/2a clinical trial in a homogeneous group of stroke patients. Stem Cells Dev. 24 (2015), 2207–2218.
167. Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006), 663–676.
168. Takamatsu, K., Ikeda, T., Haruta, M., Matsumura, K., Ogi, Y., Nakagata, N., Uchino, M., Ando, Y., Nishimura, Y., Senju, S., Degradation of amyloid beta by human induced pluripotent stem cell-derived macrophages expressing Neprilysin-2. Stem Cell Res. 13 (2014), 442–453.
169. Tang, Y.H., Ma, Y.Y., Zhang, Z.J., Wang, Y.T., Yang, G.Y., Opportunities and challenges: stem cell-based therapy for the treatment of ischemic stroke. CNS Neurosci. Ther. 21 (2015), 337–347.
170. Trzaska, K.A., Rameshwar, P., Current advances in the treatment of Parkinson's disease with stem cells. Curr. Neurovasc. Res. 4 (2007), 99–109.
171. Tumbar, T., Guasch, G., Greco, V., Blanpain, C., Lowry, W.E., Rendl, M., Fuchs, E., Defining the epithelial stem cell niche in skin. Science 303 (2004), 359–363.
172. Urdzikova, L.M., Ruzicka, J., LaBagnara, M., Karova, K., Kubinova, S., Jirakova, K., Murali, R., Sykova, E., Jhanwar-Uniyal, M., Jendelova, P., Human mesenchymal stem cells modulate inflammatory cytokines after spinal cord injury in rat. Int. J. Mol. Sci. 15 (2014), 11275–11293.
173. Venkataramana, N.K., Kumar, S.K., Balaraju, S., Radhakrishnan, R.C., Bansal, A., Dixit, A., Rao, D.K., Das, M., Jan, M., Gupta, P.K., Totey, S.M., Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease. Transl. Res. 155 (2010), 62–70.
174. Wang, S., Young, K.M., White matter plasticity in adulthood. Neuroscience 276 (2014), 148–160.
175. Wang, J., Chao, F., Han, F., Zhang, G., Xi, Q., Li, J., Jiang, H., Wang, J., Yu, G., Tian, M., Zhang, H., PET demonstrates functional recovery after transplantation of induced pluripotent stem cells in a rat model of cerebral ischemic injury. J. Nucl. Med. 54 (2013), 785–792.
176. Wang, C., Fei, Y., Xu, C., Zhao, Y., Pan, Y., Bone marrow mesenchymal stem cells ameliorate neurological deficits and blood-brain barrier dysfunction after intracerebral hemorrhage in spontaneously hypertensive rats. Int. J. Clin. Exp. Pathol. 8 (2015), 4715–4724.
177. Wang, J., Xia, J., Zhang, F., Shi, Y., Wu, Y., Pu, H., Liou, A.K., Leak, R.K., Yu, X., Chen, L., Chen, J., Galectin-1-secreting neural stem cells elicit long-term neuroprotection against ischemic brain injury. Sci. Rep., 5, 2015, 9621.
178. Wankhade, U.D., Shen, M., Kolhe, R., Fulzele, S., Advances in adipose-derived stem cells isolation, characterization, and application in regenerative tissue engineering. Stem Cells Int., 2016, 2016, 3206807.
179. Wei, N., Yu, S.P., Gu, X., Taylor, T.M., Song, D., Liu, X.F., Wei, L., Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice. Cell Transplant. 22 (2013), 977–991.
180. Wilson, R.S., Segawa, E., Boyle, P.A., Anagnos, S.E., Hizel, L.P., Bennett, D.A., The natural history of cognitive decline in Alzheimer's disease. Psychol. Aging 27 (2012), 1008–1017.
181. Wobus, A.M., Boheler, K.R., Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol. Rev. 85 (2005), 635–678.
182. Xiong, N., Zhang, Z., Huang, J., Chen, C., Zhang, Z., Jia, M., Xiong, J., Liu, X., Wang, F., Cao, X., Liang, Z., Sun, S., Lin, Z., Wang, T., VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease. Gene Ther. 18 (2011), 394–402.
183. Xu, J., Murphy, S.L., Kochanek, K.D., Bastian, B.A., Deaths: final data for 2013. Natl. Vital Stat. Rep. 64 (2016), 1–119.
184. Yan, Z.J., Hu, Y.Q., Zhang, H.T., Zhang, P., Xiao, Z.Y., Sun, X.L., Cai, Y.Q., Hu, C.C., Xu, R.X., Comparison of the neural differentiation potential of human mesenchymal stem cells from amniotic fluid and adult bone marrow. Cell. Mol. Neurobiol. 33 (2013), 465–475.
185. Yan-Wu, G., Yi-Quan, K., Ming, L., Ying-Qian, C., Xiao-Dan, J., Shi-Zhong, Z., Wang-Ming, Z., Chuan-Zhi, D., Human umbilical cord-derived Schwann-like cell transplantation combined with neurotrophin-3 administration in dyskinesia of rats with spinal cord injury. Neurochem. Res. 36 (2011), 783–792.
186. Yang, B., Strong, R., Sharma, S., Brenneman, M., Mallikarjunarao, K., Xi, X., Grotta, J.C., Aronowski, J., Savitz, S.I., Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke. J. Neurosci. Res. 89 (2011), 833–839.
187. Yang, S., Lu, W., Zhou, D.S., Tang, Y., Enriched environment and white matter in aging brain. Anat. Rec. (Hoboken) 295 (2012), 1406–1414.
188. Yang, B., Migliati, E., Parsha, K., Schaar, K., Xi, X., Aronowski, J., Savitz, S.I., Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke. Stroke 44 (2013), 3463–3472.
189. Ye, M., Wang, X.J., Zhang, Y.H., Lu, G.Q., Liang, L., Xu, J.Y., Chen, S.D., Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease. Brain Res. 1142 (2007), 206–216.
190. Yeh, D.C., Chan, T.M., Harn, H.J., Chiou, T.W., Chen, H.S., Lin, Z.S., Lin, S.Z., Adipose tissue-derived stem cells in neural regenerative medicine. Cell Transplant. 24 (2015), 487–492.
191. Yin, F., Tian, Z.M., Liu, S., Zhao, Q.J., Wang, R.M., Shen, L., Wieman, J., Yan, Y., Transplantation of human retinal pigment epithelium cells in the treatment for Parkinson disease. CNS Neurosci. Ther. 18 (2012), 1012–1020.
192. Yuan, T., Liao, W., Feng, N.H., Lou, Y.L., Niu, X., Zhang, A.J., Wang, Y., Deng, Z.F., Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion. Stem Cell Res. Ther., 4, 2013, 73.
193. Zhang, W., Wang, P.J., Sha, H.Y., Ni, J., Li, M.H., Gu, G.J., Neural stem cell transplants improve cognitive function without altering amyloid pathology in an APP/PS1 double transgenic model of Alzheimer's disease. Mol. Neurobiol. 50 (2014), 423–437.
194. Zhou, Y., Sun, M., Li, H., Yan, M., He, Z., Wang, W., Wang, W., Lu, S., Recovery of behavioral symptoms in hemi-parkinsonian rhesus monkeys through combined gene and stem cell therapy. Cytotherapy 15 (2013), 467–480.
195. Zhou, X., Gu, J., Gu, Y., He, M., Bi, Y., Chen, J., Li, T., Human umbilical cord-derived mesenchymal stem cells improve learning and memory function in hypoxic-ischemic brain-damaged rats via an IL-8-mediated secretion mechanism rather than differentiation pattern induction. Cell. Physiol. Biochem. 35 (2015), 2383–2401.
196. Zlokovic, B.V., Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 12 (2011), 723–738.
197. de Lazaro, I., Yilmazer, A., Kostarelos, K., Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics. J. Control. Release 185 (2014), 37–44.